Price target
13.320.000.00%
The 6 analysts offering 1 year price forecasts for 0ABW have a max estimate of — and a min estimate of —.
Analyst rating
Based on 5 analysts giving stock ratings to 0ABW in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
0ABW EPS for the last quarter is −0.28 SEK despite the estimation of −0.30 SEK. In the next quarter EPS is expected to reach −0.26 SEK. Track more of EGETIS THERAPEUTICS AB NPV financials and stay on top of what is up with the company.
In the next quarter EGETIS THERAPEUTICS AB NPV revenue is expected to reach 15.30 M SEK. Check out EGETIS THERAPEUTICS AB NPV revenue and earnings and make informed decisions.
According to analysts, 0ABW price target is 13.32 SEK with a max estimate of 16.90 SEK and a min estimate of 10.00 SEK. Check if this forecast comes true in a year, meanwhile watch EGETIS THERAPEUTICS AB NPV stock price chart and keep track of the current situation with 0ABW news and stock market news.
We've gathered opinions of 5 analysts rating 0ABW stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.